Pacira Biosciences, Inc.
(NASDAQ : PCRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
HZNPHorizon Therapeutics Plc -0.51%72.285.8%$205.45m
VRXValeant Pharmaceuticals International, Inc. -1.24%17.1814.1%$101.09m
CTLTCatalent, Inc. 0.81%88.512.2%$80.02m
BHCBausch Health Cos., Inc. -1.21%17.180.0%$78.04m
JAZZJazz Pharmaceuticals Plc 2.41%123.042.4%$76.25m
TNXPTonix Pharmaceuticals Holding Corp. 22.38%1.090.5%$51.73m
PRGOPerrigo Co. Plc -1.08%52.656.8%$48.65m
ICPTIntercept Pharmaceuticals, Inc. -2.92%51.8817.2%$45.75m
GWPHGW Pharmaceuticals Plc -0.65%108.296.2%$44.81m
ARGXargenx SE 2.05%236.890.0%$44.50m
ICLRICON plc 1.16%192.144.3%$41.79m
PCRXPacira Biosciences, Inc. -0.11%61.1510.2%$41.09m
AMRNAmarin Corp. Plc 2.53%6.791.5%$40.54m
MYOKMyoKardia, Inc. 0.44%101.971.8%$39.76m
VRNAVerona Pharma Plc -6.17%7.300.0%$34.56m

Company Profile

Pacira Biosciences, Inc. operates as a holding company, which engages in the development, commercialization, and manufacture of pharmaceutical products for use in postsurgical outcomes for acute care practitioners and their patients. Its flagship product, EXPAREL, redefines pain management after surgery as an opioid-free alternative indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. The company was founded in December 2006 and is headquartered in Parsippany, NJ.